Efficacy of dietary supplement with nutraceutical composed combined with extremely-low-frequency electromagnetic fields in carpal tunnel syndrome

• Published in: Journal of Physical Therapy Science Vol. 30; no. 6; pp. 777 - 784
• Main Authors: Saraceni, Vincenzo Maria, Marsilli, Gabriella, Torre, Giuseppe La, Vulpiani, Maria Chiara, Villani, Ciro, Piccinini, Giulia, Paolucci, Teresa, Nusca, Sveva Maria, Mannocci, Alice
• Format: Journal Article
• Language: English
• Published: Japan The Society of Physical Therapy Science 01.01.2018; Japan Science and Technology Agency
• Subjects: Carpal tunnel syndrome; Dietary supplements; Electromagnetism; Functional foods & nutraceuticals; Magnetic fields; Nutraceuticals; Original; Magnetic fields; Carpal tunnel syndrome; Nutraceuticals
• ISSN: 0915-5287; 2187-5626
• DOI: 10.1589/jpts.30.777

[Purpose] The aim of this study was to investigate the clinical effects of a nutraceutical composed (Xinepa®) combined with extremely-low-frequency electromagnetic fields in the carpal tunnel syndrome. [Subjects and Methods] Thirty-one patients with carpal tunnel syndrome were randomized into group 1-A (N=16) (nutraceutical + extremely-low-frequency electromagnetic fields) and group 2-C (n=15) (placebo + extremely-low-frequency electromagnetic fields). The dietary supplement with nutraceutical was twice daily for one month in the 1-A group and both groups received extremely-low-frequency electromagnetic fields at the level of the carpal tunnel 3 times per week for 12 sessions. The Visual Analogue Scale for pain, the Symptoms Severity Scale and Functional Severity Scale of the Boston Carpal Tunnel Questionnaire were used at pre-treatment (T0), after the end of treatment (T1) and at 3 months post-treatment (T2). [Results] At T1 and T2 were not significant differences in outcome measures between the two groups. In group 1-A a significant improvement in the scales were observed at T1 and T2. In group 2-C it was observed only at T1. [Conclusion] Significant clinical effects from pre-treatment to the end of treatment were shown in both groups. Only in group 1-A they were maintained at 3 months post-treatment.